sb 204070a has been researched along with yohimbine in 1 studies
Studies (sb 204070a) | Trials (sb 204070a) | Recent Studies (post-2010) (sb 204070a) | Studies (yohimbine) | Trials (yohimbine) | Recent Studies (post-2010) (yohimbine) |
---|---|---|---|---|---|
45 | 0 | 4 | 5,893 | 253 | 532 |
Protein | Taxonomy | sb 204070a (IC50) | yohimbine (IC50) |
---|---|---|---|
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.0353 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 1.02 | |
D(2) dopamine receptor | Homo sapiens (human) | 2.06 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.0428 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.0466 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.126 | |
Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0682 | |
Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0682 | |
Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0682 | |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 1.013 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.126 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.074 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 1.689 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Leclere, PG; Lefebvre, RA | 1 |
1 other study(ies) available for sb 204070a and yohimbine
Article | Year |
---|---|
Presynaptic modulation of cholinergic neurotransmission in the human proximal stomach.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Atropine; Benzofurans; Brimonidine Tartrate; Dioxanes; Enzyme Inhibitors; Evoked Potentials; Female; Gastric Fundus; Gastrointestinal Agents; Humans; Male; Middle Aged; Muscarinic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroprusside; Piperidines; Quinoxalines; Receptors, Cholinergic; Receptors, Muscarinic; Receptors, Presynaptic; Receptors, Serotonin; Receptors, Serotonin, 5-HT4; Receptors, Vasoactive Intestinal Peptide; Serotonin Antagonists; Stomach; Synaptic Transmission; Vasoactive Intestinal Peptide; Yohimbine | 2002 |